section name header

Introduction

The thrombin clotting time (TCT, plasma thrombin time) test is used to evaluate the common final pathway of the coagulation sequence. Preformed thrombin (coagulation factor IIa), usually of bovine origin, can be added to the blood sample to convert fibrinogen (factor I) directly to a fibrin clot. Because the test bypasses the intrinsic and extrinsic pathways, deficiencies in either one do not affect the TCT (see Fig. 2-1).

Thrombin-induced clotting is very rapid, and the test result can be standardized to any desired normal value (usually 10 to 15 seconds). The TCT is prolonged if fibrinogen levels are below 100 mg/dL (normal: 150 to 400 mg/dL), if the fibrinogen present is functioning abnormally, or if fibrinogen inhibitors (e.g., streptokinase, urokinase) are present (see below). In all of these conditions, the PT and PTT also are prolonged.33

Reference Values

Interfering Factors

Indications

Care Before Procedure

Nursing Care Before the Procedure

In general, client preparation is the same as that for any study involving the collection of a peripheral blood sample (see Appendix I).

Procedure

A venipuncture is performed and the sample collected in a light-blue-topped tube. Traumatic venipunctures and excessive agitation of the sample should be avoided.

Care After Procedure

Nursing Care After the Procedure

Care and assessment after the procedure are essentially the same as for any study involving the collection of a peripheral blood sample.